Intellia Therapeutics Inc (NTLA)
21.17
-0.36
(-1.67%)
USD |
NASDAQ |
Apr 24, 16:00
21.60
+0.43
(+2.03%)
Pre-Market: 08:39
Intellia Therapeutics Cash from Operations (TTM): -394.09M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -394.09M |
September 30, 2023 | -390.90M |
June 30, 2023 | -368.05M |
March 31, 2023 | -362.81M |
December 31, 2022 | -333.29M |
September 30, 2022 | -298.07M |
June 30, 2022 | -284.56M |
March 31, 2022 | -252.46M |
December 31, 2021 | -225.03M |
September 30, 2021 | -210.60M |
June 30, 2021 | -174.14M |
March 31, 2021 | -63.74M |
December 31, 2020 | -49.91M |
September 30, 2020 | -38.35M |
June 30, 2020 | -35.24M |
March 31, 2020 | -120.33M |
December 31, 2019 | -103.24M |
Date | Value |
---|---|
September 30, 2019 | -83.12M |
June 30, 2019 | -70.12M |
March 31, 2019 | -64.94M |
December 31, 2018 | -61.26M |
September 30, 2018 | -74.02M |
June 30, 2018 | -78.46M |
March 31, 2018 | -71.65M |
December 31, 2017 | -65.28M |
September 30, 2017 | -58.38M |
June 30, 2017 | -49.10M |
March 31, 2017 | 34.13M |
December 31, 2016 | 36.11M |
September 30, 2016 | 45.03M |
June 30, 2016 | 49.37M |
March 31, 2016 | -16.01M |
December 31, 2015 | -1.763M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-394.09M
Minimum
Dec 2023
-35.24M
Maximum
Jun 2020
-203.06M
Average
-210.60M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Moderna Inc | -3.118B |
Regeneron Pharmaceuticals Inc | 4.594B |
NeuroMetrix Inc | -6.085M |
Repligen Corp | 113.92M |
Pacific Biosciences of California Inc | -259.17M |